scispace - formally typeset
C

Caterina Garone

Researcher at University of Bologna

Publications -  59
Citations -  2812

Caterina Garone is an academic researcher from University of Bologna. The author has contributed to research in topics: Mitochondrial DNA & Mitochondrion. The author has an hindex of 28, co-authored 57 publications receiving 2363 citations. Previous affiliations of Caterina Garone include MRC Mitochondrial Biology Unit & Columbia University Medical Center.

Papers
More filters
Journal ArticleDOI

Mutations in CTC1, encoding conserved telomere maintenance component 1, cause Coats plus

Beverley Anderson, +66 more
- 01 Mar 2012 - 
TL;DR: Coats plus results from mutations in CTC1, encoding conserved telomere maintenance component 1, a member of the mammalian homolog of the yeast heterotrimeric CST telomeric capping complex, stimulating the activity of DNA polymerase-α primase, the only enzyme known to initiate DNA replication in eukaryotic cells.
Journal ArticleDOI

Clinical and genetic spectrum of mitochondrial neurogastrointestinal encephalomyopathy

TL;DR: Early and accurate diagnosis of mitochondrial neurogastrointestinal encephalomyopathy, together with timely treatment of acute intercurrent illnesses, may retard disease progression and increase the number of patients eligible for allogeneic haematopoetic stem cell transplantation.
Journal ArticleDOI

Recurrent De Novo and Biallelic Variation of ATAD3A, Encoding a Mitochondrial Membrane Protein, Results in Distinct Neurological Syndromes.

TL;DR: It is concluded that the p.Arg528Trp variant functions through a dominant-negative mechanism that results in small mitochondria that trigger mitophagy, resulting in a reduction in mitochondrial content.
Journal ArticleDOI

Requirement of enhanced Survival Motoneuron protein imposed during neuromuscular junction maturation

TL;DR: It is demonstrated that relative maturity of the NMJ determines the temporal requirement for the SMN protein, and the use of potent but potentially deleterious SMN-enhancing agents could be tapered in human patients once the neuromuscular system matures and reintroduced as needed to enhance SMN for remodeling aged or injured NMJs.